Oral corticosteroids were found to reduce the risk of AP (HR: 0.83, 95% CI: 0.73–0.94), whereas antirheumatic drugs or tumor necrosis factor blockers did not reduce the risk [28]. The gene discussed is TNF; the disease is alkaline phosphatase measurement.